Activest Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Activest Wealth Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.5K	Sell	166 -299	-64%	-$16.4K	﹤0.01%	591
2026 Q1	$26.3K	Buy	465 +27	+6%	+$1.57K	﹤0.01%	458
2025 Q4	$26K	Buy	+438	New	+$23.8K	﹤0.01%	443
2023 Q1	–	Sell	-2,141	Closed	-$181K	–	343
2022 Q4	$181K	Hold	2,141	–	–	0.05%	92
2022 Q3	$181K	Buy	+2,141	New	+$191K	0.06%	92

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Activest Wealth Management's BMRN Position: Q2 2026 in Review

Activest Wealth Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 64% in Q2 2026, selling an estimated $16.4K and leaving 166 shares worth $9.5K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Activest Wealth Management first reported a position in BMRN in Q3 2022 and has held it in 5 quarters since. The position peaked at $181K in Q3 2022. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Activest Wealth Management held 166 shares of BioMarin Pharmaceuticals worth $9.5K as of Q2 2026.
Activest Wealth Management sold 299 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $16.4K.
BioMarin Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #591 holding.
Activest Wealth Management first reported a position in BioMarin Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
Activest Wealth Management's BioMarin Pharmaceuticals position peaked at $181K in Q3 2022.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.